These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20577973)
1. New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance. Lee JH; Bae IK; Lee SH Med Res Rev; 2012 Jan; 32(1):216-32. PubMed ID: 20577973 [TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of antibiotic resistance and genotypes on extended spectrum β-lactamase and AmpC β-lactamase producing strains isolated from Uygur and Han newborns]. Zhang WL; Liu J; Zhang J; Su GL Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):217-24. PubMed ID: 21624232 [TBL] [Abstract][Full Text] [Related]
6. Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae. Livermore DM; Mushtaq S; Nguyen T; Warner M Int J Antimicrob Agents; 2011 May; 37(5):405-9. PubMed ID: 21276715 [TBL] [Abstract][Full Text] [Related]
7. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L; J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721 [TBL] [Abstract][Full Text] [Related]
10. A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Voets GM; Fluit AC; Scharringa J; Cohen Stuart J; Leverstein-van Hall MA Int J Antimicrob Agents; 2011 Apr; 37(4):356-9. PubMed ID: 21353487 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae. Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740 [TBL] [Abstract][Full Text] [Related]
12. Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. Cohen Stuart J; Dierikx C; Al Naiemi N; Karczmarek A; Van Hoek AH; Vos P; Fluit AC; Scharringa J; Duim B; Mevius D; Leverstein-Van Hall MA J Antimicrob Chemother; 2010 Jul; 65(7):1377-81. PubMed ID: 20462947 [TBL] [Abstract][Full Text] [Related]
13. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. Dallenne C; Da Costa A; Decré D; Favier C; Arlet G J Antimicrob Chemother; 2010 Mar; 65(3):490-5. PubMed ID: 20071363 [TBL] [Abstract][Full Text] [Related]
14. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). Cuzon G; Naas T; Bogaerts P; Glupczynski Y; Nordmann P J Antimicrob Chemother; 2012 Aug; 67(8):1865-9. PubMed ID: 22604450 [TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum beta-lactamases in North America, 1987-2006. Bush K Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():134-43. PubMed ID: 18154537 [TBL] [Abstract][Full Text] [Related]
20. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases. Shah AA; Hasan F; Ahmed S; Hameed A Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]